Although the stage of CKD was not clearly defined in this study, increased C3 mRNA and positive immunostaining for C3 in tubules were observed in patients with FSGS compared with healthy controls, supporting the role of complement activation in the progression of this kidney disease. This evidence concerns the gene C3 and kidney disorder.